Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Alan Hirzel, Jonathan Milner, Peter Keen, Louise Patten

Premium

Abcam, a Cambridge, UK-based provider of antibody microarrays, this week announced a series of management changes.

Alan Hirzel has been appointed CEO, succeeding Jonathan Milner. Hirzel previously was chief markeing officer at Abcam and has served on its board since January. Milner will continue to serve as deputy chairman of Abcam's board and remains the company's largest shareholder.

Abcam also said this week that Peter Keen will not seek re-election to the company's board. Keen has sat on Abcam's board since 2005, where he was chairman of the remuneration and audit committees, as well as senior independent director. Abcam said that Louise Patten will assume the senior independent director role following the company's annual general meeting in November.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.